Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Organon invites applications for a Project Packaging Support Engineer on a 24-month fixed-term contract in Cramlington, Northumberland. The role supports transformation projects across design, installation, commissioning, validation, testing and implementation, with site-based responsibilities.
You will act as SME for packaging equipment, drive continuous improvements, ensure cGMP compliance, and collaborate with cross-functional teams and external contractors.
Organon is hiring a Project Packaging Support Engineer (FTC) to join our Transformation team in Cramlington, Northumberland. This is a unique opportunity to play a key role in delivering a major capital investment project.
Organon delivers ingenious health solutions that enable people to live their best lives. We are a $6.5 billion global healthcare company focused on making a world of difference for women, their families and the communities they care for. We have an important portfolio and are growing it by investing in the unmet needs of Women's Health, expanding access to leading biosimilars and touching lives with a diverse and trusted portfolio of health solutions. Our Vision is clear: A better and healthier every day for every woman. As an equal opportunity employer, we welcome applications from candidates with a diverse background. We are committed to creating an inclusive environment for all our applicants.
At Organon, we aspire to improve the lives of people globally by unleashing the promise of trusted brands across women's health and other important therapeutic areas. We are committed to becoming the world's leading women's health company investing in innovations that support women's wellbeing. Fueled by its leading contraceptives and fertility businesses, Organon will invest in innovations that support the distinct health care needs of women today. Organon will also focus on its important biosimilars business, focusing on oncology and inflammatory diseases, while also maximizing the value of its trusted dermatology, pain, respiratory and cardiovascular portfolio in countries around the world where there is still great need for these treatments.